메뉴 건너뛰기




Volumn 17, Issue 8, 2016, Pages

Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population?

Author keywords

BRCA1 2; Disparities; Genetic counseling; Hereditary ovarian cancer

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PLATINUM COMPLEX;

EID: 84975864576     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-016-0417-1     Document Type: Review
Times cited : (27)

References (44)
  • 2
    • 77953687835 scopus 로고    scopus 로고
    • Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach
    • PID: 20483517
    • Kim S, Dolecek TA, Davis FG. Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach. Soc Sci Med. 2010;71(2):274–81.
    • (2010) Soc Sci Med , vol.71 , Issue.2 , pp. 274-281
    • Kim, S.1    Dolecek, T.A.2    Davis, F.G.3
  • 3
    • 0036178190 scopus 로고    scopus 로고
    • Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer
    • PID: 11801872
    • Narod SA, Boyd J. Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer. Curr Opin Obstet Gynecol. 2002;14(1):19–26.
    • (2002) Curr Opin Obstet Gynecol , vol.14 , Issue.1 , pp. 19-26
    • Narod, S.A.1    Boyd, J.2
  • 4
    • 84975806705 scopus 로고    scopus 로고
    • Inherited Mutations in Women With Ovarian Carcinoma
    • Norquist, B.M., et al., : p. 1–9. Using next generation sequencing techniques the authors demonstrate that close to 20% of ovarian cancer is associated with a germline mutation in a cancer susceptibility gene. The majority of these are in BRCA1/2
    • Norquist, B.M., et al., Inherited Mutations in Women With Ovarian Carcinoma. JAMA Oncol, 2015: p. 1–9. Using next generation sequencing techniques the authors demonstrate that close to 20% of ovarian cancer is associated with a germline mutation in a cancer susceptibility gene. The majority of these are in BRCA1/2.
    • (2015) JAMA Oncol
  • 5
    • 34248170114 scopus 로고    scopus 로고
    • Meta-analysis of BRCA1 and BRCA2 penetrance
    • PID: 17416853
    • Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25(11):1329–33.
    • (2007) J Clin Oncol , vol.25 , Issue.11 , pp. 1329-1333
    • Chen, S.1    Parmigiani, G.2
  • 6
    • 77956193440 scopus 로고    scopus 로고
    • Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
    • COI: 1:CAS:528:DC%2BC3cXhtFWjsbrF, PID: 20810374
    • Domchek SM et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967–75.
    • (2010) JAMA , vol.304 , Issue.9 , pp. 967-975
    • Domchek, S.M.1
  • 7
    • 84964696210 scopus 로고    scopus 로고
    • Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers
    • PID: 25494812
    • Marchetti C et al. Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers. BMC Womens Health. 2014;14:150.
    • (2014) BMC Womens Health , vol.14 , pp. 150
    • Marchetti, C.1
  • 8
    • 40749132232 scopus 로고    scopus 로고
    • International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
    • COI: 1:CAS:528:DC%2BD1cXkt1ChsL8%3D, PID: 18196574
    • Metcalfe KA et al. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer. 2008;122(9):2017–22.
    • (2008) Int J Cancer , vol.122 , Issue.9 , pp. 2017-2022
    • Metcalfe, K.A.1
  • 9
    • 79958036419 scopus 로고    scopus 로고
    • Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
    • COI: 1:CAS:528:DC%2BC3MXntlyksLg%3D, PID: 21642681
    • Buys SS et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA. 2011;305(22):2295–303.
    • (2011) JAMA , vol.305 , Issue.22 , pp. 2295-2303
    • Buys, S.S.1
  • 10
    • 0032514413 scopus 로고    scopus 로고
    • Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group
    • COI: 1:CAS:528:DyaK1cXlslWgtLw%3D, PID: 9700175
    • Narod SA et al. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med. 1998;339(7):424–8.
    • (1998) N Engl J Med , vol.339 , Issue.7 , pp. 424-428
    • Narod, S.A.1
  • 11
    • 0037021659 scopus 로고    scopus 로고
    • Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    • COI: 1:CAS:528:DC%2BD38XptlOitLo%3D, PID: 12464649
    • Narod SA et al. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2002;94(23):1773–9.
    • (2002) J Natl Cancer Inst , vol.94 , Issue.23 , pp. 1773-1779
    • Narod, S.A.1
  • 12
    • 33846187651 scopus 로고    scopus 로고
    • A candidate precursor to serous carcinoma that originates in the distal fallopian tube
    • COI: 1:CAS:528:DC%2BD2sXhs1yqurs%3D, PID: 17117391
    • Lee Y et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007;211(1):26–35.
    • (2007) J Pathol , vol.211 , Issue.1 , pp. 26-35
    • Lee, Y.1
  • 13
    • 77954110971 scopus 로고    scopus 로고
    • Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications
    • PID: 20567141
    • Carlson JW et al. Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications. Int J Gynecol Pathol. 2010;29(4):310–4.
    • (2010) Int J Gynecol Pathol , vol.29 , Issue.4 , pp. 310-314
    • Carlson, J.W.1
  • 14
    • 10544220023 scopus 로고    scopus 로고
    • Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1
    • COI: 1:STN:280:DyaK2s%2FivF2qtg%3D%3D, PID: 8875917
    • Rubin SC et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med. 1996;335(19):1413–6.
    • (1996) N Engl J Med , vol.335 , Issue.19 , pp. 1413-1416
    • Rubin, S.C.1
  • 15
    • 57149093237 scopus 로고    scopus 로고
    • "BRCAness" syndrome in ovarian cancer: a case–control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations
    • PID: 18955455
    • Tan DS et al. "BRCAness" syndrome in ovarian cancer: a case–control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. J Clin Oncol. 2008;26(34):5530–6.
    • (2008) J Clin Oncol , vol.26 , Issue.34 , pp. 5530-5536
    • Tan, D.S.1
  • 16
    • 77955039099 scopus 로고    scopus 로고
    • Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
    • COI: 1:CAS:528:DC%2BC3cXpt1Kktb4%3D, PID: 20609468
    • Audeh MW et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet. 2010;376(9737):245–51.
    • (2010) Lancet , vol.376 , Issue.9737 , pp. 245-251
    • Audeh, M.W.1
  • 17
    • 84953204390 scopus 로고    scopus 로고
    • Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy
    • COI: 1:CAS:528:DC%2BC2MXitV2rs7zP, PID: 26723501
    • Domchek SM et al. Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy. Gynecol Oncol. 2016;140(2):199–203.
    • (2016) Gynecol Oncol , vol.140 , Issue.2 , pp. 199-203
    • Domchek, S.M.1
  • 18
    • 84894268890 scopus 로고    scopus 로고
    • Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation
    • PID: 24366442
    • Nelson HD et al. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2014;160(4):255–66.
    • (2014) Ann Intern Med , vol.160 , Issue.4 , pp. 255-266
    • Nelson, H.D.1
  • 19
    • 84943787980 scopus 로고    scopus 로고
    • BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance
    • Eccles, D.M., et al., BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance. Ann Oncol, 2015.
    • (2015) Ann Oncol
    • Eccles, D.M.1
  • 20
    • 70349651005 scopus 로고    scopus 로고
    • Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups
    • COI: 1:STN:280:DC%2BD1MnjvFOhtw%3D%3D, PID: 19491284
    • Haffty BG et al. Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Ann Oncol. 2009;20(10):1653–9.
    • (2009) Ann Oncol , vol.20 , Issue.10 , pp. 1653-1659
    • Haffty, B.G.1
  • 21
    • 65649112508 scopus 로고    scopus 로고
    • BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer
    • COI: 1:CAS:528:DC%2BD1MXlvFOhsrw%3D, PID: 19241424
    • Hall MJ et al. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer. 2009;115(10):2222–33.
    • (2009) Cancer , vol.115 , Issue.10 , pp. 2222-2233
    • Hall, M.J.1
  • 22
    • 84933574451 scopus 로고    scopus 로고
    • Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer
    • PID: 25847940
    • Jagsi R et al. Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. J Clin Oncol. 2015;33(14):1584–91.
    • (2015) J Clin Oncol , vol.33 , Issue.14 , pp. 1584-1591
    • Jagsi, R.1
  • 23
    • 0037087536 scopus 로고    scopus 로고
    • Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals
    • COI: 1:CAS:528:DC%2BD38XivFeisbY%3D, PID: 11896095
    • Frank TS et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20(6):1480–90.
    • (2002) J Clin Oncol , vol.20 , Issue.6 , pp. 1480-1490
    • Frank, T.S.1
  • 24
    • 0032565070 scopus 로고    scopus 로고
    • Frequency of breast cancer attributable to BRCA1 in a population-based series of American women
    • COI: 1:CAS:528:DyaK1cXitlyju7Y%3D, PID: 9544765
    • Newman B et al. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA. 1998;279(12):915–21.
    • (1998) JAMA , vol.279 , Issue.12 , pp. 915-921
    • Newman, B.1
  • 25
    • 37549036689 scopus 로고    scopus 로고
    • Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups
    • COI: 1:CAS:528:DC%2BD1cXmvFOr, PID: 18159056
    • John EM et al. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA. 2007;298(24):2869–76.
    • (2007) JAMA , vol.298 , Issue.24 , pp. 2869-2876
    • John, E.M.1
  • 26
    • 33748092354 scopus 로고    scopus 로고
    • Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years
    • COI: 1:CAS:528:DC%2BD28XotFWqu74%3D, PID: 16912212
    • Malone KE et al. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res. 2006;66(16):8297–308.
    • (2006) Cancer Res , vol.66 , Issue.16 , pp. 8297-8308
    • Malone, K.E.1
  • 27
    • 84948582795 scopus 로고    scopus 로고
    • A high frequency of BRCA mutations in young black women with breast cancer residing in Florida, Cancer
    • Pal, T., et al., A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Cancer, 2015.
    • (2015) et al.
    • Pal, T.1
  • 28
    • 84939252201 scopus 로고    scopus 로고
    • Deleterious BRCA1/2 mutations in an urban population of Black women
    • COI: 1:CAS:528:DC%2BC2MXhtlelsbzK, PID: 26250392
    • Lynce F et al. Deleterious BRCA1/2 mutations in an urban population of Black women. Breast Cancer Res Treat. 2015;153(1):201–9.
    • (2015) Breast Cancer Res Treat , vol.153 , Issue.1 , pp. 201-209
    • Lynce, F.1
  • 29
    • 16444381731 scopus 로고    scopus 로고
    • Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer
    • COI: 1:CAS:528:DC%2BD2MXjtlWmtLc%3D, PID: 15827311
    • Armstrong K et al. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA. 2005;293(14):1729–36.
    • (2005) JAMA , vol.293 , Issue.14 , pp. 1729-1736
    • Armstrong, K.1
  • 30
    • 37849013468 scopus 로고    scopus 로고
    • Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer
    • PID: 18165638
    • Susswein LR et al. Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer. J Clin Oncol. 2008;26(1):32–6.
    • (2008) J Clin Oncol , vol.26 , Issue.1 , pp. 32-36
    • Susswein, L.R.1
  • 31
    • 79955009383 scopus 로고    scopus 로고
    • Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk
    • PID: 21358336
    • Levy DE et al. Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med. 2011;13(4):349–55.
    • (2011) Genet Med , vol.13 , Issue.4 , pp. 349-355
    • Levy, D.E.1
  • 32
    • 84921362893 scopus 로고    scopus 로고
    • American BRCA Outcomes and Utilization of Testing (ABOUT) study: a pragmatic research model that incorporates personalized medicine/patient-centered outcomes in a real world setting
    • PID: 25209347
    • Armstrong J et al. American BRCA Outcomes and Utilization of Testing (ABOUT) study: a pragmatic research model that incorporates personalized medicine/patient-centered outcomes in a real world setting. J Genet Couns. 2015;24(1):18–28.
    • (2015) J Genet Couns , vol.24 , Issue.1 , pp. 18-28
    • Armstrong, J.1
  • 34
    • 33645457117 scopus 로고    scopus 로고
    • Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups
    • PID: 16434605
    • Kaplan CP et al. Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups. Cancer Epidemiol Biomarkers Prev. 2006;15(1):162–6.
    • (2006) Cancer Epidemiol Biomarkers Prev , vol.15 , Issue.1 , pp. 162-166
    • Kaplan, C.P.1
  • 35
    • 84978473330 scopus 로고    scopus 로고
    • [cited 2014 December 20]; Available from
    • Pew Internet and American Life Project. 2014 [cited 2014 December 20]; Available from: http://www.pewinternet.org/fact-sheets/health-fact-sheet/.
    • (2014) Pew Internet and American Life Project
  • 37
    • 68349121468 scopus 로고    scopus 로고
    • Addressing social determinants of health to improve access to early breast cancer detection: results of the Boston REACH 2010 Breast and Cervical Cancer Coalition Women’s Health Demonstration Project
    • Clark CR et al. Addressing social determinants of health to improve access to early breast cancer detection: results of the Boston REACH 2010 Breast and Cervical Cancer Coalition Women’s Health Demonstration Project. J Women’s Health. 2009;18(5):677–90.
    • (2009) J Women’s Health , vol.18 , Issue.5 , pp. 677-690
    • Clark, C.R.1
  • 38
    • 84921644693 scopus 로고    scopus 로고
    • Multiple barriers delay care among women with abnormal cancer screening despite patient navigation
    • Ramachandran A et al. Multiple barriers delay care among women with abnormal cancer screening despite patient navigation. J Women’s Health. 2015;24(1):30–6.
    • (2015) J Women’s Health , vol.24 , Issue.1 , pp. 30-36
    • Ramachandran, A.1
  • 39
    • 84923083184 scopus 로고    scopus 로고
    • Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women
    • Percac-Lima S et al. Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women. J Women’s Health. 2015;24(2):138–43.
    • (2015) J Women’s Health , vol.24 , Issue.2 , pp. 138-143
    • Percac-Lima, S.1
  • 41
    • 78751580532 scopus 로고    scopus 로고
    • Patient navigation: the promise to reduce health disparities
    • PID: 21161422
    • Freund KM. Patient navigation: the promise to reduce health disparities. J Gen Intern Med. 2011;26(2):110–2.
    • (2011) J Gen Intern Med , vol.26 , Issue.2 , pp. 110-112
    • Freund, K.M.1
  • 42
    • 79960710009 scopus 로고    scopus 로고
    • Assessing the impact of patient navigation: prevention and early detection metrics
    • PID: 21780090
    • Battaglia TA et al. Assessing the impact of patient navigation: prevention and early detection metrics. Cancer. 2011;117(15 Suppl):3553–64.
    • (2011) Cancer , vol.117 , pp. 3553-3564
    • Battaglia, T.A.1
  • 43
    • 79960708066 scopus 로고    scopus 로고
    • History and principles of patient navigation
    • PID: 21780088
    • Freeman HP, Rodriguez RL. History and principles of patient navigation. Cancer. 2011;117(15 Suppl):3539–42.
    • (2011) Cancer , vol.117 , pp. 3539-3542
    • Freeman, H.P.1    Rodriguez, R.L.2
  • 44
    • 84909641270 scopus 로고    scopus 로고
    • Bridging the gap: a community health program saved lives, then closed its doors
    • Behforouz HL. Bridging the gap: a community health program saved lives, then closed its doors. Health Aff. 2014;33(11):2064–7.
    • (2014) Health Aff , vol.33 , Issue.11 , pp. 2064-2067
    • Behforouz, H.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.